Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer

OBJECTIVE: Adjuvant chemotherapy (AC) improves survival of patients with resected non-small cell lung cancer (NSCLC). However, the cisplatin-vinorelbine regimen has been associated with a significant risk of clinically relevant toxicity. We sought to evaluate the effectiveness, safety, and feasibili...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Guilherme, Neffa, Maria Fernanda Batistuzzo Vicentini, Bonadio, Renata Colombo, Mendoza, Elizabeth Zambrano, Caparica, Rafael, Lauricella, Letícia Leone, Takagaki, Teresa Yae, Roitberg, Felipe Santa Rosa, Terra, Ricardo Mingarini, Castro, Gilberto De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332712/
https://www.ncbi.nlm.nih.gov/pubmed/33656100
http://dx.doi.org/10.36416/1806-3756/e20200378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332712/
https://www.ncbi.nlm.nih.gov/pubmed/33656100
http://dx.doi.org/10.36416/1806-3756/e20200378

Ejemplares similares